Moderate-intensity continuous training (MICT) for Atrial Fibrillation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Atrial Fibrillation+2 MoreModerate-intensity continuous training (MICT) - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether exercise can help relieve symptoms in people with atrial fibrillation.

Eligible Conditions
  • Atrial Fibrillation

Treatment Effectiveness

Study Objectives

5 Primary · 2 Secondary · Reporting Duration: Through study completion, an average of 1.5 years

Week 3
AF status measured daily with a KardiaMobile device
AF symptoms self-reported with a 7-day patient symptom questionnaire
Week 2
Feasibility of the pilot study - Participant fidelity
Year 5
Feasibility of the pilot study - Adverse events
Feasibility of the pilot study - Recruitment and consent rate
Feasibility of the pilot study - Study eligibility refinement
Feasibility of the pilot study - Study retention

Trial Safety

Trial Design

3 Treatment Groups

Rest
1 of 3
High Intensity Interval Training (HIIT)
1 of 3
Moderate Intensity Continuous Training (MICT)
1 of 3

Active Control

Experimental Treatment

36 Total Participants · 3 Treatment Groups

Primary Treatment: Moderate-intensity continuous training (MICT) · No Placebo Group · N/A

High Intensity Interval Training (HIIT)
Behavioral
Experimental Group · 1 Intervention: High-intensity interval training (HIIT) · Intervention Types: Behavioral
Moderate Intensity Continuous Training (MICT)
Behavioral
Experimental Group · 1 Intervention: Moderate-intensity continuous training (MICT) · Intervention Types: Behavioral
RestNoIntervention Group · 1 Intervention: Rest · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High-intensity interval training (HIIT)
2016
N/A
~270

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 1.5 years

Who is running the clinical trial?

Ottawa Heart Institute Research CorporationLead Sponsor
179 Previous Clinical Trials
87,796 Total Patients Enrolled
23 Trials studying Atrial Fibrillation
6,943 Patients Enrolled for Atrial Fibrillation
Jennifer Reed, PhDPrincipal InvestigatorOttawa Heart Institute Research Corporation
2 Previous Clinical Trials
172 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a resting ventricular rate of less than 110 bpm.
You are at least 40 years of age.